A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
KN046 in Patients With Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
NADIM II: Neo-Adjuvant Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)
- Status
- COMPLETED
- Phase
- PHASE3
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE4
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2